Additionally, several studies have shown that MyD88 is associated with clinicopathological features, such as histological subtypes of ovarian cancer [30,40], cell metastasis of breast cancer [41], and lymphatic metastasis [42]. Here, MYD88 is linked to ovarian carcinoma.